Product Categories
| Country: | China |
|---|---|
| Tel: | 02118516225986 |
| Mobile: | 18516225986 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Dapagliflozin-004 | C14H12BrClO2 | 1284798-26-0 | Details |
| 7-methoxy-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid | C12H14O3 | 24833-31-6 | Details |
| Di-n-butylmagnesium | C8H18Mg | 1191-47-5 | Details |
| CCT129202 | C23H25ClN8OS | 942947-93-5 | Details |
| 2-Boc-5-oxo-octahydro-isoindole | C13H21NO3 | 203661-68-1 | Details |
| 4-Bromo-1-chloro-2-(4-methoxy-benzyl)-benzene | C14H12BrClO | 333361-51-6 | Details |
| (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4- hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | C27H29ClO10 | 1079083-63-8 | Details |
| N-(2,3-dichlorophenyl)ethane-1,2-diamine | C8H10Cl2N2 | 40779-32-6 | Details |
| IDO-IN-4 | C26H35N3O3 | 1629125-65-0 | Details |
| 4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl | C30H28Cl2O2 | 2176485-21-3 | Details |
| 2-(3,5-Dihydroxyphenyl)acetic acid | C8H8O4 | 4670-09-1 | Details |
| Ortho-Isomer of Dapagliflozin | C21H25ClO6 | 2040305-05-1 | Details |
| 3-(4-Chlorophenyl)benzaldehyde | C13H9ClO | 139502-80-0 | Details |
| (1S,4S)-2-thia-5-azabicyclo[2.2.1]heptane 2,2-dioxide hydrochloride | C5H10ClNO2S | 1481613-21-1 | Details |
| 2-chloro-4-(trifluoromethyl)benzaldehyde oxime | C8H7ClF3N | 361393-93-3 | Details |
| 3,4-Dimethyl-1H-pyrrole-2,5-dione | C6H7NO2 | 17825-86-4 | Details |
| 5,6-DICHLORO-2,3-DICYANOPYRAZINE | C6Cl2N4 | 56413-95-7 | Details |
| 2-(BROMOMETHYL)-3,5,6-TRIMETHYLPYRAZINE | C8H11BrN2 | 79074-45-6 | Details |
| tert-butyl (1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate | C10H17NO3 | 905306-11-8 | Details |
| 2,2'-(2,5-difluorocyclohexa-2,5-diene-1,4-diylidene)dipropanedinitrile | C12H2F2N4 | 73318-02-2 | Details |
| 4,6-dimethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)Pyrimidine | C12H19BN2O2 | 1430233-43-4 | Details |
| 4-bromo-1-chloro-2-(2-ethoxybenzyl)benzene | C15H14BrClO | 1830346-16-1 | Details |
| Ethyl 4-mercaptobenzoate | C9H10O2S | 28276-32-6 | Details |
| Dapagliflozin Impurity 10 | C21H25ClO7 | 461432-27-9 | Details |
| 2-hydroxycycloheptanone | C7H12O2 | 4436-58-2 | Details |
| (1S,4S)-2-Thia-5-(t-butoxycarbonyl)-5-azabicyclo[2.2.1]heptane | C10H17NO2S | 125094-90-8 | Details |
| 2-METHYL-4-HEPTANONE | C8H16O | 626-33-5 | Details |
| Methanone, (5-chloro-2-iodophenyl)(4-ethoxyphenyl)- | C15H12ClIO2 | 1981926-74-2 | Details |
| 2-chloro-4-(trifluoromethyl)benzaldehyde oxime | C8H5ClF3NO | 1188445-87-5 | Details |
| Dapagliflozin Impurity 48 | C15H14Cl2O | 2069934-29-6 | Details |
| (1R,4R)-5-tert-butoxycarbonyl-2-oxa-5-azabicyclo[2.2.1]heptane-4-carboxylic acid | C11H17NO5 | 1932204-83-5 | Details |
| 5,6-DIAMINO-2,3-DICYANOPYRAZINE | C6H4N6 | 36023-58-2 | Details |
| 2,4,6,8-Tetrachloropyrimido[5,4-d]pyrimidine | C6Cl4N4 | 32980-71-5 | Details |
| (R)-2-Oxa-5-aza-bicyclo[2.2.1]heptane-5-carboxylic acid tert-butyl ester | C10H17NO3 | 114676-79-8 | Details |
| (S)-3-(Methylsulfonyl)pyrrolidine hydrochloride | C5H12ClNO2S | 1407997-84-5 | Details |
| (3R,4R,5R,6S)-2-(acetoxyMethyl)-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate | C22H27ClO7 | 461432-24-6 | Details |
| 3-(2,3,5-trimethyl-1,4-benzoquinonyl)-3-methylbutyric acid | C14H18O4 | 40662-29-1 | Details |
| TERT-BUTYL 5-HYDROXYHEXAHYDRO-1H-ISOINDOLE-2(3H)-CARBOXYLATE | C13H23NO3 | 203661-67-0 | Details |
| tert-butyl 3-methylenecyclobutanecarboxylate | C10H16O2 | 122699-51-8 | Details |
| (2,5-dibromophenyl)(4-ethoxyphenyl)methanone | C15H12Br2O2 | 1713015-63-4 | Details |
| INDEX NAME NOT YET ASSIGNED | C31H37ClO10 | 2770409-19-1 | Details |
| Benzene,1-ethoxy-4-(phenylmethyl)- | C15H16O | 35672-52-7 | Details |
| 2-Oxa-5-azabicyclo[2.2.1]heptane-5-carboxylic acid, 4-(hydroxymethyl)-, 1,1-dimethylethyl ester | C11H19NO4 | 2413869-36-8 | Details |
| 2-METHYL-4-OCTANONE | C9H18O | 7492-38-8 | Details |
| CGP 48664A | C11H15ClN6 | 138794-73-7 | Details |
| (1R,2R)-2-iodocyclopropanecarboxylic acid | C4H5IO2 | 692288-05-4 | Details |
| Canagliflozin Impurity 16 | C15H14Br2O | 1807632-93-4 | Details |
| Dapagliflozin Impurity 8 | C15H12ClIO2 | 2305949-33-9 | Details |
| 2-Bromo-3,4-dihydroxybenzaldehyde | C7H5BrO3 | 4815-97-8 | Details |
| (2-Chloro-5-((3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenyl)(4-ethoxyphenyl)methanone | C21H23ClO7 | 2169998-23-4 | Details |
| 1-Chloro-2-[(4-ethoxyphenyl)methyl]benzene | C15H15ClO | 1662702-90-0 | Details |
| (1R,4S)-4-(hydroxymethyl)-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylic acid tert-butyl ester | C11H19NO4 | 2643374-05-2 | Details |
| (1S,4S)-5-[(2-methylpropan-2-yl)oxycarbonyl]-2-oxa-5-azabicyclo[2.2.1]heptane-4-carboxylic acidster | C11H17NO5 | 2920198-60-1 | Details |
| 2-Oxa-7-azaspiro[3.5]nonane | C7H13NO | 241820-91-7 | Details |
| 4,5-Dichloro-3-nitropyridin-2-amine | C5H3Cl2N3O2 | 662116-67-8 | Details |
| (5-broMo-2-chloro-phenyl)-(4-ethoxy-phenyl)-Methanone | C14H10BrClO2 | 333361-49-2 | Details |
| (cis)2-iodocyclopropanecarboxylic acid | C4H5IO2 | 122676-92-0 | Details |
| endo-3-Boc-3-azabicyclo[3.1.0]hexane-6-carboxylic acid | C11H17NO4 | 1401464-07-0 | Details |
| (5-bromo-2-chlorophenyl)(4-ethyloxyphenyl)methanol | C15H14BrClO2 | 1280647-32-6 | Details |
| BMS-639432 | C21H25ClO7 | 1204222-85-4 | Details |
| 5-BROMO-2-CHLORO-BENZOYL CHLORIDE | C7H3BrCl2O | 21900-52-7 | Details |
| (1S,2S)-2-iodocyclopropanecarboxylic acid | C4H5IO2 | 1932315-23-5 | Details |
| 1,4,5,6-TETRAHYDRO-5,6-DIOXO-2,3-PYRAZINEDICARBONITRILE | C6H2N4O2 | 36023-64-0 | Details |
| 2-(4-bromo-2,5-difluorophenyl)malononitrile | C9H3BrF2N2 | 2412591-86-5 | Details |
| Desethylene Aripiprazole | C21H25Cl2N3O2 | 1216394-63-6 | Details |
| Phenol, 4-chloro-3-[(4-ethoxyphenyl)methyl]- | C15H15ClO2 | 1408077-50-8 | Details |
| (2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)phenyl)-6-(hydroxyl methyl)tetrahydro-2H-pyran-3,4,5-triol | C21H26O6 | 2452300-89-7 | Details |
| (2,5-dichlorophenyl)(4-ethoxyphenyl)methanone | C15H12Cl2O2 | 1097076-93-1 | Details |
| 6-hydroxy-4,4,5,7,8-pentamethylchroman-2-one | C14H18O3 | 40662-76-8 | Details |
| Cyclopropanamine, 2-[4-(trifluoromethyl)phenyl]-, hydrochloride (1:1), (1R,2S)-rel- | C10H11ClF3N | 819046-96-3 | Details |
| 7-hydroxy-1,2,3,4-tetrahydronaphthalene-2-carboxylic acid | C11H12O3 | 31846-36-3 | Details |
| α-D-Glucopyranoside, methyl 1-C-[4-chloro-3-[(4-methoxyphenyl)methyl]phenyl]- | C21H25ClO7 | 1210040-47-3 | Details |
| 2-Thia-5-azabicyclo[2.2.1]heptane-5-carboxylic acid, 1,1-dimethylethyl ester | C10H17NO2S | 937612-68-5 | Details |
| (1S,4S)-5-tert-butoxycarbonyl-2-oxa-5-azabicyclo[2.2.1]heptane-4-carboxylic acid methyl ester | C12H19NO5 | 2643373-99-1 | Details |
| 2-METHYL-4-OCTANOL | C9H20O | 40575-41-5 | Details |
| Dapagliflozin iMpurity | C21H25BrO6 | 1807632-95-6 | Details |
| 2-METHYL-4-HEPTANOL | C8H18O | 21570-35-4 | Details |
| Dapagliflozin Impurity 20 | C29H33ClO10 | 2040305-09-5 | Details |
| D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-methoxyphenyl)methyl]phenyl]-, (1S)- | C20H23ClO6 | 333359-90-3 | Details |
| Dapagliflozin Impurity 9 | C15H14ClIO | 2305949-36-2 | Details |
| 2-(3,4,5-trihydroxyphenyl)acetic acid | C8H8O5 | 29511-09-9 | Details |
| 3-benzyl-3-azabicyclo[3.3.1]nonan-9-ol | C15H21NO | 866615-27-2 | Details |
| 2-Oxa-7-azaspiro[3.5]nonane-7-carboxylic acid, 1,1-dimethylethyl ester | C12H21NO3 | 240401-27-8 | Details |
| Resveratrol 3,4’Diacetate | C18H16O5 | 861446-14-2 | Details |
| (2R,3S,4R,5R,6S)-6-(4-chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)Methyl acetate | C19H21ClO6 | 864070-37-1 | Details |
| (5-broMo-2-chlorophenyl)(2-ethoxyphenyl)Methanone | C15H12BrClO2 | 1404477-10-6 | Details |
| (1R,4R)-benzyl 2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate | C13H15NO3 | 787640-37-3 | Details |
| 1-bromo-3-(4-ethoxybenzyl)benzene | C15H15BrO | 898538-17-5 | Details |
| 4-hydroxy-3′,5′-diacetyl-trans-stilbene | C18H16O5 | 411233-14-2 | Details |
| 3,4-Dimethylpyrrolidine-2,5-dione | C6H9NO2 | 33425-47-7 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||